By Gene Bruno, MS, MHS – Dean of Academics, Huntington College of Health Sciences. Ashwagandha, an adaptogen rich in phytochemicals, provides a multitude of health benefits.

Ashwagandha (Withania somnifera) is an herb that grows in India, Pakistan, Afghanistan, Spain, parts of the Middle East, Africa, and the Canary Islands.  It is sometimes called “Indian ginseng.” probably because it is employed as an adaptogen or tonic in Ayurvedic traditional medicine. (1)  It is not, however, related to “true” ginseng (P. ginseng, P. quinquifolium). The root is used medicinally, although the seeds, shoots, juice and leaves have all been used traditionally as well. (2)

Phytochemical contents

Ashwagandha has been found to contain steroidal lactones called withanolides. Much of the pharmacological activities Ashwagandha are attributed to the presence of these steroidal lactones. (3, 4) In addition, the roots provide alkaloids, 18 fatty acids, Beta Sitosterol , polyphenols and phytosterols. (5)

Common uses

Traditional use of Ashwagandha includes its use as an aphrodisiac. As a folk remedy, it has a long list of uses. It is listed in the Indian Materia Medica, and is part of Ayurvedic, Siddha, and Unani traditions.  Published research on Ashwagandha reveals a variety of potentially valuable and diverse uses for improving and supporting health.  Following is a discussion of each of these potential uses.

Chemotherapy and radiation therapy

Chemotherapy and radiation therapy are commonly used to treat individuals with cancer.  One problem associated with both of these treatments are that they can reduce white blood cell (WBC) count; and chemotherapy can cause mylosuppression—a reduced capcity of bone marrow to produce WBC.  In turn, this can lead to patient susceptibility to other infections.  Animal research has shown that Ashwagandha is capable of increasing WBC count when used with either chemotherapy or radiation therapy. (6,7)  Similar research has shown that this herb can also reduce mylosuppression in association with chemotherapy. (8)

In addition, several studies have shown Ashwagandha to be effective at inhibiting tumor growth in test animals while enhancing radiosensitivity, the ability of radiation therapy to kill tumor cells. (9, 10, 11, 12, 13, 14)  In one study, Ashwagandha was able to inhibit tumor growth in animals even without radiation therapy.  (15)

Immune function

Besides it potential for treating cancer, research has shown that Ashwagandha is capable of improving immune function.  This was demonstrated in one study where mice experienced an increase phagocytosis and intracellular  macrophage activity against a pathogen when given a daily dose of Ashwagandha. (16)  In another study on mice, Ashwagandha was shown to improve the tumor-fighting ability of macrophages in relation to a known carcinogen. (17) Ashwagandha has also prevented myelosuppression in mice  treated with immunosuppressive drugs, and led to a significant increase in hemoglobin concentration, red blood cell count, white blood cell count, platelet count, and body weight, in addition to providing immunostimulatory activity. (18)

Finally, in a series of experiments various techniques were used to suppress the immune response of mice, then subjected them to infectious organisms. In each experiment, mice pretreated with one of six herbs, including Ashwagandha, fared significantly better than control mice.  Mice receiving the herbs demonstrated faster recovery, less disease, and lower mortality. These herbs blunted artificially-induced neutropenia (a deficit of neutrophils, a type of white blood cell) and stimulated leucocytosis (an increase of white blood cells). In treatments that employed both antibiotics and a these herbs the combination produced a significantly greater healing effect than either treatment used alone.  The herbs also reduced stress-induced damage. (19)

Antioxidant activity

Apparently, one of Ashwagandha’s mechanisms of action is that it has significant antioxidant activity.  In one study, Ashwagandha significantly reduced free radical oxidation in the liver of mice, while concurrently increasing the activity of antioxidant enzymes such as superoxide dismutase (SOD) and catalase. (20) Other research has shown that Ashwagandha reduced free radical activity in stress‑induced animals. (21)  In another study, Ashwagandha administered once daily for 21 days, induced a dose‑related increase in SOD, catalase, and glutathione peroxidase in rats. (22)  One interesting study showed that as part of an Ayurvedic herbal formulation, Ashwagandha increased SOD activity in the pancreas of diabetic rats. (23)

Brain chemistry

Ashwagandha has also been used in the treatment of mental and emotional well-being, since it can  influence brain chemistry in positive ways.  For example it has been shown to be capable of improving memory and enhancing cognitive function in animal research by improving acetylcholine activity in the brain and binding to acetylcholine receptor sites. (24)  This herb is also has GABA‑mimetic activity—that is it can mimic some of the activity of the relaxing neurotransmitter GABA. (25) Clinical trials have shown that Ashwagandha can alleviate a reactive type of depression without sedating. Instead, it “optimizes mental and psychomotor performance by easing the mental stress bundle.” (26)


In a clinical trial of ashwagandha on the aging process in over 100 men, 71.4% of the men reported improvement in their capacity of sexual performance. These responses seem to support the herb’s traditional use as an aphrodisiac. (27)

Anti-inflammatory & antiarthritic activity

Ashwagandha has demonstrated some very effective anti-inflammatory activity.  In fact, in one study its anti-inflammatory activity was comparable to that of a 5 mg/kg dose of hydrocortisone. (28)  In another study, five plants were assessed for their anti-inflammatory activity. Results showed that while each of the plants possessed varying degrees of anti‑inflammatory activity, Ashwagandha possessed the greatest.  (29)

Perhaps the anti-inflammatory activity of Ashwagandha explains its efficacy in arthritis.  In a one-month study, a combination of Ashwagandha, Boswellia serrata, Tumeric, and zinc were given to 42 patients with osteoarthritis.  At the end of the study, there was a significant drop in severity of pain and disability. (30)

Anti-stress & Anabolic activity

Given their relative similarities in function, a comparative study was performed on Ginseng (Panax ginseng), and Ashwagandha (Withania somnifera). Using aqueous suspensions of the powdered root, each herb was tested in mice: (1) for anti-stress activity (by the swimming endurance test); and (2) anabolic activity (by the weight measurement of body weight and levator ani muscle).  In the swimming endurance test, Ashwagandha and Ginseng each showed anti-stress activity as compared to the control group, although the activity was higher with Ginseng.  In the anabolic study, the mice treated with Ashwagandha showed a greater gain in body weight than those treated with Ginseng, although significant anabolic activity was observed for both herbs. (31)

Morphine dependance

Although only tested thus far in mice, Ashwagandha may help reduce dependance on morphine.  In a 10-day study, Ashwagandha, helped prevent tolerance to morphine from developing.  This is important since developing a tolerance for a drug often leads to increased doses and abuses.  Also, Ashwagandha suppressed morphine‑withdrawal jumps, a sign of the development of dependence to morphine.(32)

Glandular support

As if all of the aforementioned benefits weren’t sufficient, Ashwagandha also supports the function of the thyroid, liver and pancreas.  After being administered on a daily basis for 20 days, mice experienced an increase in boh T3 and T4 thyroid hormones.  In the same study, Ashwagandha also decreased free radical activity in the liver. (33)  In another study, a combination of Ashwagandha and other herbs (Tinospora cordifolia, Eclipta alba, Ocimum sanctum, Picrorrhiza  kurroa and shilajit) administered once daily for 28 days decreased blood sugar levels in diabetic rats, and decreased free radical activity in their pancreas’ as well.  This activity in the pancreas is important since the reduction in blood sugar may be due to pancreatic free radical scavenging  activity, which protects the cells that produce insulin. (34)


To determine any potential toxicity of Ashwagandha (as well as Panax Ginseng), at study was conducted in rats with 90 days oral administration using three doses.  Food consumption, body weight, haematological,  biochemical and histopathological parameters were studied.  The results were that brain, heart, lung, liver, spleen, kidneys, stomach, testis and ovaries were normal on gross examination and histopathologically.  Subacute toxicity studies in rats did not reveal any toxicity. (35) Apparently, Ashwagandha is a safe herb.  Even so, one research has suggested that Ashwagandha is contraindicated during pregnancy. (36)

Posted April 13, 2010.


  1. Choudhary M, et al, Phytochemistry (1995) 40(4):1243-6.
  2. Lindner S, Australian Journal of Medical Herbalism (1996) 8(3):78-82.
  3. Choudhary M, et al, Phytochemistry (1995) 40(4):1243-6.
  4. Elsakka M, et al, Rev Med Chir Soc Med Nat Iasi (1990) 94(2):385‑7.
  5. Ibid.
  6. Davis L, Kuttan G, J Ethnopharmacol (1998) 62(3):209‑14.
  7. Kuttan G, Indian J Exp Biol (1996) 34(9):854‑6.
  8. Praveenkumar V, et al, Tumori (1994) 80(4):306‑8.
  9. Ganasoundari A, Zare SM, Devi PU, Br J Radiol (1997) 70(834):599‑602.
  10. Devi PU, Indian J Exp Biol (1996) 34(10):927‑32
  11. Sharad AC, et al, Acta Oncol (1996) 35(1):95‑100.
  12. Devi PU, Int J Radiat Biol (1996) 69(2):193‑7.
  13. Devi PU, Sharada AC, Solomon FE, Cancer Lett (1995) 95(1‑2):189‑93.
  14. Devi PU, Sharada AC, Solomon FE, Indian J Exp Biol (1993) 31(7):607‑11.
  15. Devi PU, et al, Indian J Exp Biol (1992) 30(3):169‑72.
  16. Dhuley JN, Immunopharmacol Immunotoxicol (1998) 20(1):191‑8.
  17. Dhuley JN, J Ethnopharmacol (1997) 58(1):15‑20
  18. Ziauddin M, J Ethnopharmacol (1996) 50(2):69‑76.
  19. Dahanukar S, Thatte U, Phytomedicine (1997) 4(4):359-368.
  20. Panda S, Kar A, J Pharm Pharmacol (1998) 50(9):1065‑8.
  21. Dhuley JN, J Ethnopharmacol (1998) 60(2):173‑8.
  22. Bhattacharya SK, Satyan KS, Ghosal S, Indian J Exp Biol (1997) 35(3):236‑9.
  23. Bhattacharya SK, Satyan KS, Chakrabarti A, Indian J Exp Biol (1997) 35(3):297‑9.]
  24. Schliebs R, et al, Neurochem Int (1997) 30(2):181‑90.
  25. Mehta AK, et al, Indian J Med Res (1991) 94:312‑5.
  26. Katiyar CK, et al, Immunomodulator Products from Ayurveda: Current status and future perspectives. In: Immunomodulation, S.N. Upadhyay (Ed), (1997) Narosa Publishing House, New Delhi, India, pp. 163-187.
  27. Linder, op cit
  28. al‑Hindawi MK, al‑Khafaji SH, Abdul‑Nabi MH, J Ethnopharmacol (1992) 37(2):113‑6.
  29. Al‑Hindawi MK, et al, J Ethnopharmacol (1989) 26(2):163‑8.
  30. Kulkarni RR, et al, J Ethnopharmacol (1991) 33(1‑2):91‑5.
  31. Grandhi, et al, Journal of Ethnopharmacology (1994) 44:131-135.
  32. Kulkarni SK, Ninan I, J Ethnopharmacol (1997) 57(3):213‑7.
  33. Panda S, Kar A, J Pharm Pharmacol (1998) 50(9):1065‑8.
  34. Bhattacharya SK, Satyan KS, Chakrabarti A, Indian J Exp Biol (1997) 35(3):297‑9.
  35. Aphale AA, et al, Indian J Physiol  Pharmacol (1998) 42(2):299‑302.
  36. Linder, op cit